The Pathophysiology of Tourette Syndrome: a Multimodal Study
PTS
fMRI Study on Iron Deficiency in the Pathological Mechanism of Tourette Syndrome
1 other identifier
observational
40
1 country
1
Brief Summary
The purpose of this study is to characterize the functional and anatomical connectivity changes in Tourette syndrome and its relation with iron deficiency.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 13, 2014
CompletedFirst Posted
Study publicly available on registry
July 15, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedApril 27, 2016
April 1, 2016
2.9 years
May 13, 2014
April 26, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Amplitude of low frequency fluctuation of BOLD signal in Tourette syndrome and its relation with iron deficiency
Amplitude of low frequency fluctuation of BOLD signal has proven to be a promising way to detect disease-related local brain activity.This study investigate ALFF in Tourette syndrome and provides insights into the pathological mechanism of Tourette syndrome
two years
Secondary Outcomes (1)
Brain iron levels in Tourette syndrome
two years
Eligibility Criteria
Patients were recruited from outpatients or inpatients with Tourette syndrome.
You may qualify if:
- years old
- Characterized by vocal tic and muscle twitch
- No positive signs was found through neurological examination, no significant psychomotor retardation,
You may not qualify if:
- Hepatolenticular degeneration
- Rheumatic chorea
- Myoclonic epilepsy
- History of mental disease or brain trauma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Second Affiliated Hospital,Zhejiang University,School of Medicine
Hangzhou, Zhejiang, 310009, China
Biospecimen
no biospecimens are to be retained
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jianhua Feng, Doctor
Second affiliated hospital,zhejiang University,school of medicine,
- PRINCIPAL INVESTIGATOR
Jianhua Feng, Doctor
Secon Affiliated Hospital,Zhejiang University,School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor of medicine
Study Record Dates
First Submitted
May 13, 2014
First Posted
July 15, 2015
Study Start
December 1, 2013
Primary Completion
November 1, 2016
Study Completion
April 1, 2017
Last Updated
April 27, 2016
Record last verified: 2016-04